Invivyd develops antibody therapies to prevent and treat serious viral infections, starting with COVID-19. It last closed at $0.41 on Nov 20, down 7.45% on the day. The next earnings report for IVVD is expected around Thu, Mar 4, 2027. For the quarter ended Sep 2026, IVVD reported EPS of -$0.10 on revenue of $15.4M, with revenue up 17.7% from a year ago. Over its last 8 reports the stock moved an average of 8.6% the session after earnings. Over the last 12 months IVVD insiders bought $0 of stock on the open market and sold $532K, according to SEC Form 4 filings.
AI Auto Pilots
Is IVVD in one of our AI portfolios?
Five AI traders run real portfolios in the open, with every decision logged. Create a free account to see if they hold IVVD.
Close to close, the session after each report, adjusted for splits. Past moves are no guide to the next one.
StreetAlpha callBullish64%
OPTIONS
+2
DARK POOL
+1
HISTORY
0
TECHNICAL
+1
StreetAlpha's call on IVVDStart your 7 day free trial to see StreetAlpha's call before the report, with the options flow, dark pool, history and technical scores behind it.Sign up freeSign in
IVVD · as of the Nov 20 close · updated each morning
Downtrend, oversold
The stock is 36% below its 20 day and 67% below its 50 day average. It is 155% below its 200 day average, so the longer trend is down. Momentum is weak (RSI 28), oversold. The nearest support is the 52 week low at $0.41, and the nearest resistance the Pivot at $0.43.
Short trendBearish
Long trendBearish
MomentumWeak
StretchOversold
VolatilityHigh, 14.2%/day
Key levels
$3.0152 week high+634.1%
$1.05200 day average+156.1%
$0.73100 day average+78.0%
$0.6950 day average+68.3%
$0.64Swing high (Oct 29)+56.1%
$0.5620 day average+36.6%
$0.45Pivot R1+9.8%
$0.43Pivot+4.9%
$0.4152 week low+0.0%
$0.41Last close
$0.39Pivot S1−4.9%
Indicators
RSI (14)
27.60
Oversold below 30
Oversold
MACD
-0.06
Below its signal line
Bearish
Stochastic
2.0
Near the bottom of its range
Oversold
ADX (14)
24.0
Weak trend
Williams %R
-100.0
Oversold below −80, overbought above −20
Oversold
CCI (20)
-237.6
Oversold below −100, overbought above 100
Oversold
Rate of change
−26.7%
Change over 10 sessions
Bearish
ATR (14)
$0.06
Typical daily range, 14.2% of price
MA 10Below
MA 20Below
MA 50Below
MA 100Below
MA 200Below
Downtrend, nearing oversold
Short trendBearish
Long trendBearish
MomentumWeak
StretchNear oversold
VolatilityNormal, 45.7%/day
Key levels
$3.0152 week high+634.1%
$1.05200 day average+156.1%
$0.73100 day average+78.0%
$0.6950 day average+68.3%
$0.64Swing high (Oct 29)+56.1%
$0.5620 day average+36.6%
$0.45Pivot R1+9.8%
$0.43Pivot+4.9%
$0.4152 week low+0.0%
$0.41Last close
$0.39Pivot S1−4.9%
Indicators
RSI (14)
33.56
Weak, oversold below 30
Neutral
MACD
-0.17
Below its signal line
Bearish
Stochastic
4.6
Near the bottom of its range
Oversold
ADX (14)
18.4
No clear trend
Williams %R
-100.0
Oversold below −80, overbought above −20
Oversold
CCI (20)
-144.7
Oversold below −100, overbought above 100
Oversold
Rate of change
−47.5%
Change over 10 sessions
Bearish
ATR (14)
$0.19
Typical daily range, 45.7% of price
MA 10Below
MA 20Below
MA 50Below
MA 100Below
MA 200Below
What happened before, for IVVD
Signal name goes hereSince a recent date
9 times
+0.0%
Signal name goes hereSince a recent date
9 times
+0.0%
Signal name goes hereSince a recent date
9 times
+0.0%
What happened before
See how IVVD did after each of today's signals in the past: how often it was higher 10 sessions later, and the typical move, next to its usual record. Free with an account.
November seasonalityHow IVVD usually does this month. See Seasonality
Calculated from daily prices after each close. Signals describe the chart, not where the stock will go. Past patterns often fail. Not investment advice.
AI Day Trader
Watch Claude day trade the open, live.
Every session it trades SPY, QQQ, IWM and two daily stock picks, with each call logged before the move.
Whale options flow for IVVDHow many large options trades hit IVVD, the bullish and bearish split, and every trade with strike, premium and expiry are shown to AI Starter and AI Pro members.Sign up freeSign in
No whale options trades in IVVD in the last 90 days.
From SEC Form 4 filings by IVVD's officers, directors and 10% owners. Open market buys and sales only; option exercises, gifts, awards and tax withholding are left out. Not investment advice.
AI Auto Pilots
Paper trading
StreetAlpha runs autonomous AI traders powered by Anthropic's Claude. Each one reads options flow, dark pool prints, insider filings, sentiment, macro signals and technicals, then makes its own trading decisions in a paper portfolio. Every decision is logged and every trade is tracked, so you can see whether IVVD is in one of them and how their past IVVD trades turned out.
Invivyd is a biopharmaceutical company based in New Haven, Connecticut, that develops antibody therapies for serious viral infectious diseases. Its first authorized product, PEMGARDA, is an antibody used to help prevent COVID-19 in people who are immunocompromised and unlikely to respond well to vaccination. The company is also developing next generation COVID-19 antibodies and early candidates for diseases such as RSV and measles. Its customers are mainly patients and the healthcare providers who treat them.